In Situ Production and Secretion of Proteins Endow Therapeutic Benefit against Psoriasiform Dermatitis and Melanoma

Signal peptides-engineered etanercept/TNF-α inhibitor proteins demonstrated therapeutic efficacy in an imiquimod-induced psoriasis model by reducing hyperkeratosis and inflammation.